Boston Scientific Corp. (BSX) Tops Q3 EPS by 5c; Issues Mixed Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
It Is the Same Old Story at Boston Scientific (BSX)
October 19, 2012 10:06 AM EDTJefferies maintained a Hold rating on Boston Scientific (NYSE: BSX) and raised its price target to $6.00 (from $5.00).
"At its core, the BSX investment story remains the same: weak end markets and completion in the two largest divisions are sapping growth and cost... More
